CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (43,309)	$ (102,379)
Adjustments to reconcile net loss to net cash (used in) / generated from operating activities:
Amortization of program rights	172,739	189,036
Depreciation and other amortization	86,652	86,756
Net (gain) / loss on extinguishment of debt	(448)	25,904
(Gain) / loss on disposal of fixed assets	(279)	767
Stock-based compensation (Note 14)	3,197	4,556
Change in fair value of derivatives (Note 11)	(48,884)	(4,600)
Foreign currency exchange gain, net	163	(1,452)
Net change in (net of effects of acquisitions and disposals of businesses):
Accounts receivable, net	26,371	56,338
Accounts payable and accrued liabilities	(26,417)	(28,578)
Program rights	(233,557)	(235,767)
Other assets	614	6,215
Accrued interest	(4,116)	(8,172)
Income taxes payable	(3,068)	2,572
Deferred revenue	21,267	28,936
Deferred taxes	(10,633)	(6,616)
VAT and other taxes payable	2,808	3,730
Net cash (used in) / generated from operating activities	(56,900)	17,246
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property, plant and equipment	(21,382)	(21,932)
Disposal of property, plant and equipment	301	701
Investments in subsidiaries, net of cash acquired	0	(8,847)
Net cash used in investing activities	(21,081)	(30,078)
CASH FLOWS FROM FINANCING ACTIVITIES:
Repurchase of Senior Notes	(180,087)	(73,560)
Payment on exchange of Convertible Notes	0	(32,126)
Debt transactions costs	(4,928)	(2,101)
Issuance of Senior Notes	228,890	0
Change in restricted cash	(131,020)	0
Proceeds from credit facilities	195,090	67,794
Payment of credit facilities and capital leases	(105,847)	(23,677)
Issuance of common stock	15,033	0
Equity issuance costs	(2,153)	0
Settlement of forward currency swaps	(82)	(923)
Proceeds from exercise of stock options	33	242
Dividends paid to holders of noncontrolling interests	(296)	(316)
Net cash provided by / (used) in financing activities	14,633	(64,667)
Impact of exchange rate fluctuations on cash	2,620	866
Net decrease in cash and cash equivalents	(60,728)	(76,633)
CASH AND CASH EQUIVALENTS, beginning of period	186,386	244,050
CASH AND CASH EQUIVALENTS, end of period	125,658	167,417
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:
Conversion of credit facility to shares of Series A preferred stock and Class A common stock (Note 12)	$ 165,112	$ 0